JP2022055190A - Composition containing benzalkonium chloride - Google Patents
Composition containing benzalkonium chloride Download PDFInfo
- Publication number
- JP2022055190A JP2022055190A JP2020162642A JP2020162642A JP2022055190A JP 2022055190 A JP2022055190 A JP 2022055190A JP 2020162642 A JP2020162642 A JP 2020162642A JP 2020162642 A JP2020162642 A JP 2020162642A JP 2022055190 A JP2022055190 A JP 2022055190A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- paraben
- benzalkonium chloride
- less
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 155
- 229960000686 benzalkonium chloride Drugs 0.000 title claims abstract description 50
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 title claims abstract description 50
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 65
- 239000003002 pH adjusting agent Substances 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 45
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 29
- 230000000844 anti-bacterial effect Effects 0.000 claims description 26
- 238000004659 sterilization and disinfection Methods 0.000 claims description 23
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 17
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 17
- 229960002216 methylparaben Drugs 0.000 claims description 17
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 16
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 16
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 16
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 11
- 230000001747 exhibiting effect Effects 0.000 claims description 4
- 238000012360 testing method Methods 0.000 description 20
- 239000002253 acid Substances 0.000 description 13
- 239000000645 desinfectant Substances 0.000 description 13
- -1 etc.] Chemical compound 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 238000009472 formulation Methods 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 150000005846 sugar alcohols Polymers 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000003125 aqueous solvent Substances 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000013112 stability test Methods 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000012812 general test Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000004088 foaming agent Substances 0.000 description 3
- 238000001139 pH measurement Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241001453380 Burkholderia Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229940034794 benzylparaben Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940113094 isopropylparaben Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960003476 methylparaben sodium Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本発明は、塩化ベンザルコニウムを含有する組成物等に関する。 The present invention relates to a composition containing benzalkonium chloride and the like.
塩化ベンザルコニウムは、消毒剤(消毒用成分)等として使用される成分である。
例えば、特許文献1には、繊維シートに消毒液が含浸されたウェットワイパーにおいて、消毒液を構成する消毒剤として、塩化ベンザルコニウム等を使用できることが記載されている。
Benzalkonium chloride is a component used as a disinfectant (component for disinfection) and the like.
For example, Patent Document 1 describes that benzalkonium chloride or the like can be used as a disinfectant constituting the disinfectant in a wet wiper in which a fiber sheet is impregnated with a disinfectant.
本発明の目的は、塩化ベンザルコニウムを含有する新規な組成物等を提供することにある。 An object of the present invention is to provide a novel composition or the like containing benzalkonium chloride.
塩化ベンザルコニウム(ベンザルコニウム塩化物)は、前記のように、消毒剤等として使用されている。 Benzalkonium chloride (benzalkonium chloride) is used as a disinfectant or the like as described above.
このような中、本発明者は、塩化ベンザルコニウムを、特定の条件(パラベン共存下、好ましくはさらに特定pH)で使用することにより、殺菌(抗菌)性能を効率よく発揮しうる組成物が得られうることを見出した。 Under these circumstances, the present inventor has created a composition capable of efficiently exhibiting bactericidal (antibacterial) performance by using benzalkonium chloride under specific conditions (in the coexistence of parabens, preferably further at a specific pH). I found that it could be obtained.
一方、パラベンは、防腐剤等として使用される成分であるが、本発明者の検討によれば、組成物において、経時的な分解が進行しうること、また、このような分解は、他の成分(例えば、pH調整剤)の共存下において進行しやすくなりうることがわかった。 On the other hand, paraben is a component used as a preservative or the like, but according to the study of the present inventor, decomposition may proceed over time in the composition, and such decomposition may occur in other ways. It has been found that it can be more likely to progress in the presence of components (eg, pH regulators).
このような中、本発明者は、パラベンに、塩化ベンザルコニウムを組み合わせる(特に、pH調剤剤等の他の成分の共存下において組み合わせる)ことで、パラベンの安定性(保存安定性、経時安定性、又は分解安定性)を向上又は改善しうること等も見出した。 Under these circumstances, the present inventor has combined paraben with benzalkonium chloride (particularly in the presence of other components such as a pH preparation) to stabilize the paraben (storage stability, stability over time). It was also found that the sex or decomposition stability) can be improved or improved.
すなわち、本発明は、以下の発明等に関する。
[1]
塩化ベンザルコニウム及びパラベンを含有し、pHが5.1以上である組成物。
[2]
塩化ベンザルコニウム、パラベン、及びpH調整剤を含有する組成物。
[3]
塩化ベンザルコニウムの割合が0.01~10w/v%である、[1]又は[2]記載の組成物。
[4]
パラベンが、メチルパラベン及びエチルパラベンから選択された少なくとも1種を含む、[1]~[3]のいずれかに記載の組成物。
[5]
パラベンが、メチルパラベン及びエチルパラベンを含む[1]~[4]のいずれかに記載の組成物。
[6]
パラベンの割合が1質量%以下である、[1]~[5]のいずれかに記載の組成物。
[7]
塩化ベンザルコニウム1質量部に対して、パラベンを0.05質量部以上の割合で含む、[1]~[6]のいずれかに記載の組成物。
[8]
塩基性を示すpH調整剤を含有する、[1]~[7]のいずれかに記載の組成物。
[9]
水を含有し、かつ実質的にエタノール(アルコール)を含有しない、[1]~[8]のいずれかに記載の組成物。
[10]
pHが5.3以上である[1]~[9]のいずれかに記載の組成物。
[11]
pHが5.5~7である[1]~[10]のいずれかに記載の組成物。
[12]
pHが6~6.5である[1]~[11]のいずれかに記載の組成物。
[13]
消毒用(消毒剤)である[1]~[12]のいずれかに記載の組成物。
[14]
皮膚消毒用(消毒剤)である[1]~[13]のいずれかに記載の組成物。
[15]
塩化ベンザルコニウムを含有する組成物に、パラベンを配合し、組成物の殺菌力を向上する方法。
[16]
パラベンを含有する組成物に、塩化ベンザルコニウムを配合し、組成物におけるパラベンの安定性を向上する方法。
[17]
組成物のpHを5.1以上とする、[15]又は[16]記載の方法。
[18]
組成物が、pH調整剤を含有する、[15]~[17]のいずれかに記載の方法。
That is, the present invention relates to the following inventions and the like.
[1]
A composition containing benzalkonium chloride and paraben and having a pH of 5.1 or higher.
[2]
A composition containing benzalkonium chloride, parabens, and a pH regulator.
[3]
The composition according to [1] or [2], wherein the ratio of benzalkonium chloride is 0.01 to 10 w / v%.
[4]
The composition according to any one of [1] to [3], wherein the paraben comprises at least one selected from methylparaben and ethylparaben.
[5]
The composition according to any one of [1] to [4], wherein the paraben contains methylparaben and ethylparaben.
[6]
The composition according to any one of [1] to [5], wherein the proportion of paraben is 1% by mass or less.
[7]
The composition according to any one of [1] to [6], which comprises 0.05 parts by mass or more of paraben with respect to 1 part by mass of benzalkonium chloride.
[8]
The composition according to any one of [1] to [7], which contains a pH adjuster exhibiting basicity.
[9]
The composition according to any one of [1] to [8], which contains water and substantially no ethanol (alcohol).
[10]
The composition according to any one of [1] to [9], which has a pH of 5.3 or higher.
[11]
The composition according to any one of [1] to [10], which has a pH of 5.5 to 7.
[12]
The composition according to any one of [1] to [11], which has a pH of 6 to 6.5.
[13]
The composition according to any one of [1] to [12], which is for disinfection (disinfectant).
[14]
The composition according to any one of [1] to [13], which is for skin disinfection (disinfectant).
[15]
A method of blending paraben with a composition containing benzalkonium chloride to improve the bactericidal activity of the composition.
[16]
A method of blending benzalkonium chloride with a composition containing paraben to improve the stability of paraben in the composition.
[17]
The method according to [15] or [16], wherein the pH of the composition is 5.1 or higher.
[18]
The method according to any one of [15] to [17], wherein the composition contains a pH adjuster.
本発明によれば、塩化ベンザルコニウムを含有する新規な組成物等を提供できる。 According to the present invention, it is possible to provide a novel composition or the like containing benzalkonium chloride.
このような組成物の一態様では、塩化ベンザルコニウムを特定の条件下で使用することにより、殺菌性能を効率よく発揮しうる。特に、このような組成物によれば、水系(水性組成物)や、エタノールフリーであっても、殺菌力を発揮しうる。そして、このような組成物では、殺菌力を長期にわたって維持又は保持しうる。 In one aspect of such a composition, the bactericidal performance can be efficiently exhibited by using benzalkonium chloride under specific conditions. In particular, according to such a composition, bactericidal activity can be exhibited even if it is water-based (aqueous composition) or ethanol-free. And, in such a composition, the bactericidal power can be maintained or maintained for a long period of time.
また、組成物の一態様では、パラベンの安定性を向上又は改善しうる。このような組成物によれば、水系(水性組成物)やエタノールフリーであっても[さらには、他の成分(例えば、pH調整剤等)を含有していても]、パラベンの安定性(経時安定性、分解安定性)を改善又は向上しうる。そのため、このような組成物によれば、パラベンによる機能(例えば、防腐性能)を維持又は保持しうる。 Also, in one aspect of the composition, the stability of parabens can be improved or improved. According to such compositions, the stability of parabens (even if they are water-based (aqueous composition) or ethanol-free [and even if they contain other components (eg, pH regulators)] Stability over time, decomposition stability) can be improved or improved. Therefore, according to such a composition, the function of parabens (for example, antiseptic performance) can be maintained or maintained.
さらに、組成物の一態様では、殺菌機能とパラベンの安定性(ひいては長期にわたるパラベンの機能の発揮)とを両立しうる。このような両立は、水系(水性組成物)やエタノールフリーであっても[さらには、他の成分(例えば、pH調整剤等)を含有していても]、実現しうるものである。 Furthermore, in one aspect of the composition, both bactericidal function and paraben stability (and thus paraben function over a long period of time) can be compatible. Such compatibility can be achieved even if it is water-based (aqueous composition) or ethanol-free [furthermore, even if it contains other components (for example, a pH adjuster)].
このように本発明の組成物は、有用性が高く、種々の用途に使用しうる。
特に、上記のように、エタノール(アルコール)フリーであっても、殺菌性能を発揮しうるため、アルコール過敏症の対象者に対しても使用可能な皮膚消毒用(手指消毒用)の組成物等として使用できる。
As described above, the composition of the present invention is highly useful and can be used for various purposes.
In particular, as described above, since it can exhibit bactericidal performance even if it is ethanol (alcohol) -free, it is a composition for skin disinfection (for hand disinfection) that can be used even for subjects with alcohol hypersensitivity. Can be used as.
[組成物]
本発明の組成物(製剤)は、塩化ベンザルコニウムとパラベンを少なくとも含む。
[Composition]
The composition (formulation) of the present invention contains at least benzalkonium chloride and paraben.
(塩化ベンザルコニウム)
塩化ベンザルコニウム(ベンザルコニウム塩化物)としては、例えば、第十七改正日本薬局方 医薬品各条「ベンザルコニウム塩化物」に記載の成分が挙げられる。
具体的には、塩化ベンザルコニウムは、式[C6H5CH2N(CH3)2R]Clで示される化合物であってもよい。
この式において、Rは、脂肪族炭化水素基(アルキル基)である。代表的なRには、炭素数8~18のアルキル基(C8H17~C18H37)が含まれる。Rは、主としてC12H25及びC14H29を含んで(からなって)いてもよい。
組成物において、塩化ベンザルコニウムの割合は、組成物の用途、使用目的(例えば、消毒目的、パラベンの安定化目的等)ないし使用態様(希釈する場合等)等にもよるが、例えば、0.001w/v%以上、好ましくは0.005w/v%以上、さらに好ましくは0.01w/v%以上等であってもよい。
(Benzalkonium chloride)
Examples of benzalkonium chloride (benzalkonium chloride) include the components described in the 17th revised Japanese Pharmacopoeia Pharmaceuticals Article "Benzalkonium Chloride".
Specifically, benzalkonium chloride may be a compound represented by the formula [C 6 H 5 CH 2 N (CH 3 ) 2 R] Cl.
In this formula, R is an aliphatic hydrocarbon group (alkyl group). A typical R includes an alkyl group having 8 to 18 carbon atoms (C 8 H 17 to C 18 H 37 ). R may include (consiste of) primarily C 12 H 25 and C 14 H 29 .
In the composition, the ratio of benzalkonium chloride depends on the use, purpose of use (for example, disinfection purpose, purpose of stabilizing paraben, etc.) or mode of use (when diluting, etc.) of the composition, but is, for example, 0. It may be 001 w / v% or more, preferably 0.005 w / v% or more, more preferably 0.01 w / v% or more, and the like.
塩化ベンザルコニウムの割合の上限値は、特に限定されないが、例えば、10w/v%以下、好ましくは2w/v%以下、さらに好ましくは0.2w/v%以下等であってもよい。 The upper limit of the ratio of benzalkonium chloride is not particularly limited, but may be, for example, 10 w / v% or less, preferably 2 w / v% or less, more preferably 0.2 w / v% or less.
代表的には、塩化ベンザルコニウムの割合は、例えば、0.001~10w/v%、好ましくは0.005~2w/v%、さらに好ましくは0.01~0.2w/v%等であってもよい。 Typically, the proportion of benzalkonium chloride is, for example, 0.001 to 10 w / v%, preferably 0.005 to 2 w / v%, and more preferably 0.01 to 0.2 w / v%. There may be.
なお、塩化ベンザルコニウムの割合は、製品濃度か使用濃度であるか、効能・効果等に応じて、好適な範囲を選択してもよい。
効能・効果(使用目的)ごとの好適な濃度を以下に例示する。
The ratio of benzalkonium chloride may be selected in a suitable range depending on whether it is the product concentration or the concentration used, and the efficacy / effect.
Suitable concentrations for each indication (purpose of use) are illustrated below.
手指・皮膚の消毒:0.05~0.1w/v%
手術部位の皮膚の消毒:0.1~0.2w/v%
手術部位の粘膜、皮膚・粘膜の創傷部位の消毒:0.01~0.025w/v%
感染皮膚面の消毒:0.01w/v%
医療機器の消毒:0.1w/v%
手術室・病室・家具・器具・物品などの消毒:0.05~0.2w/v%
膣洗浄:0.02~0.05w/v%
結膜嚢の洗浄・消毒:0.01~0.05w/v%
Disinfection of fingers and skin: 0.05-0.1w / v%
Disinfection of the skin at the surgical site: 0.1-0.2w / v%
Disinfection of the mucous membrane of the surgical site and the wound site of the skin / mucous membrane: 0.01-0.025w / v%
Disinfection of infected skin surface: 0.01w / v%
Disinfection of medical equipment: 0.1w / v%
Disinfection of operating rooms, hospital rooms, furniture, instruments, articles, etc .: 0.05-0.2w / v%
Vaginal lavage: 0.02-0.05w / v%
Cleaning and disinfection of the conjunctival sac: 0.01-0.05w / v%
(パラベン)
パラベンとしては、例えば、パラオキシ安息香酸アルキルエステル[例えば、メチルパラベン(パラオキシ安息香酸メチル)、エチルパラベン(パラオキシ安息香酸エチル)、プロピルパラベン、イソプロピルパラベン、ブチルパラベン、イソブチルパラベン等]、ベンジルパラベン等が挙げられる。
(Paraben)
Examples of parabens include paraoxybenzoic acid alkyl esters [eg, methylparaben (methyl paraoxybenzoate), ethylparaben (ethyl paraoxybenzoate), propylparaben, isopropylparaben, butylparaben, isobutylparaben, etc.], benzylparaben and the like. Be done.
なお、パラベンは、塩[例えば、メチルパラベンナトリウム等のように金属塩(例えば、ナトリウム塩等のアルカリ金属塩等)]を形成してもよい(又はパラベンは塩を含んでいてもよい)。 In addition, paraben may form a salt [for example, a metal salt such as methylparaben sodium (for example, an alkali metal salt such as sodium salt)] (or paraben may contain a salt).
パラベンは、単独で又は2種以上組み合わせて使用してもよい。 Parabens may be used alone or in combination of two or more.
これらのうち、パラオキシ安息香酸アルキルエステルが好ましく、特に、パラベンは、メチルパラベン及び/又はエチルパラベンを少なくとも含んでいてもよく、メチルパラベン及びエチルパラベンを含んでいてもよい。
メチルパラベンやエチルパラベン(特にメチルパラベン)は、機能(抗菌力等)、水溶解性(ひいては組成物における析出抑制)の観点から好ましく、特に機能(併用による抗菌力等の機能のさらなる向上)と水溶解性のバランス等の観点から、メチルパラベンとエチルパラベンを組み合わせることが好適である。
このようなパラベンを使用することで、溶解促進(析出抑制)のための成分(溶解助剤)を使用せずとも(又は使用を抑えて)、効率よく機能(抗菌力等)を発揮しうる。
このような溶解助剤を多量使用すると、溶解助剤に由来する別の問題(使用感の悪化、皮膚刺激性の増加等)が発生する可能性、ひいては、製剤全体のバランス調整が煩雑になり、製剤化のハードルが高くなる可能性があるが、パラベンを好適に選択することにより、このような問題を防止しうる。
Of these, paraoxybenzoic acid alkyl esters are preferable, and in particular, parabens may contain at least methylparaben and / or ethylparaben, and may contain methylparaben and ethylparaben.
Methylparaben and ethylparaben (particularly methylparaben) are preferable from the viewpoint of function (antibacterial activity, etc.) and water solubility (and thus inhibition of precipitation in the composition), and are particularly functional (further improvement of function such as antibacterial activity by combined use) and water dissolution. From the viewpoint of sex balance and the like, it is preferable to combine methylparaben and ethylparaben.
By using such a paraben, it is possible to efficiently exert its function (antibacterial activity, etc.) without using (or suppressing its use) a component (dissolution aid) for promoting dissolution (suppressing precipitation). ..
When a large amount of such a solubilizing agent is used, another problem (deterioration of usability, increased skin irritation, etc.) due to the solubilizing agent may occur, and as a result, the balance adjustment of the entire formulation becomes complicated. Although the hurdles for formulation may be high, such a problem can be prevented by appropriately selecting parabens.
パラベンが、メチルパラベン及び/又はエチルパラベンを含有する場合、パラベン全体に対するメチルパラベン及び/又はエチルパラベンの割合は、例えば、30質量%以上、好ましくは50質量%以上、さらに好ましくは70質量%以上(例えば、80質量%以上)であってもよく、90質量%以上であってもよく、100質量%(実質的にパラベンがメチルパラベン及び/又はエチルパラベンのみ)であってもよい。 When the paraben contains methylparaben and / or ethylparaben, the ratio of methylparaben and / or ethylparaben to the total paraben is, for example, 30% by mass or more, preferably 50% by mass or more, and more preferably 70% by mass or more (for example). , 80% by mass or more), 90% by mass or more, or 100% by mass (substantially parabens are methylparaben and / or ethylparaben only).
パラベンが、メチルパラベン及びエチルパラベンを含む場合、これらの比率は特に限定されないが、例えば、メチルパラベン1質量部に対して、エチルパラベン0.01~100質量部、好ましくは0.05~20質量部、さらに好ましくは0.1~10質量部であってもよい。 When the paraben contains methylparaben and ethylparaben, the ratio thereof is not particularly limited, but for example, 0.01 to 100 parts by mass, preferably 0.05 to 20 parts by mass of ethylparaben with respect to 1 part by mass of methylparaben. More preferably, it may be 0.1 to 10 parts by mass.
組成物において、パラベンの割合は、組成物の用途、使用目的(例えば、防腐目的、殺菌性能の向上等)ないし使用態様(希釈する場合等)等にもよるが、例えば、1w/v%以下、好ましくは0.5w/v%以下、さらに好ましくは0.25w/v%以下等であってもよい。 In the composition, the ratio of paraben depends on the use of the composition, the purpose of use (for example, antiseptic purpose, improvement of bactericidal performance, etc.) or the mode of use (when diluting, etc.), but is, for example, 1 w / v% or less. It may be preferably 0.5 w / v% or less, more preferably 0.25 w / v% or less, and the like.
本発明の組成物の一態様では、パラベンを安定化しうるため、比較的少ない割合(使用量)であっても、パラベンの機能を効率よく発揮しうる。 In one aspect of the composition of the present invention, since paraben can be stabilized, the function of paraben can be efficiently exhibited even in a relatively small proportion (usage amount).
パラベンの割合の下限値は、特に限定されないが、例えば、0.005w/v%以上、好ましくは0.01w/v%以上、さらに好ましくは0.02w/v%以上等であってもよい。 The lower limit of the ratio of paraben is not particularly limited, but may be, for example, 0.005 w / v% or more, preferably 0.01 w / v% or more, and more preferably 0.02 w / v% or more.
代表的には、パラベンの割合は、例えば、0.005~1w/v%、好ましくは0.01~0.5w/v%、さらに好ましくは0.02~0.25w/v%等であってもよい。 Typically, the proportion of parabens is, for example, 0.005 to 1 w / v%, preferably 0.01 to 0.5 w / v%, more preferably 0.02 to 0.25 w / v%, and the like. You may.
塩化ベンザルコニウムとパラベンの割合は、例えば、塩化ベンザルコニウム1質量部に対して、パラベン0.01質量部以上(例えば、0.05質量部以上)、好ましくは0.1質量部以上、さらに好ましくは0.2質量部以上であってもよく、20質量部以下、好ましくは10質量部以下、さらに好ましくは5質量部以下であってもよい。 The ratio of benzalkonium chloride to paraben is, for example, 0.01 part by mass or more (for example, 0.05 part by mass or more), preferably 0.1 part by mass or more, with respect to 1 part by mass of benzalkonium chloride. It may be more preferably 0.2 parts by mass or more, 20 parts by mass or less, preferably 10 parts by mass or less, and further preferably 5 parts by mass or less.
(pH調整剤)
組成物は、pH調整剤を含んでいてもよい。pH調整剤としては、pHを調整(変動)できる成分であれば特に限定されず、所望のpHに応じて適宜選択でき、塩基性(塩基性成分)であってもよく、酸性(酸性成分、酸成分)であってもよい。
(PH regulator)
The composition may include a pH regulator. The pH adjuster is not particularly limited as long as it is a component that can adjust (variate) the pH, and can be appropriately selected according to a desired pH, and may be a basic (basic component) or an acidic (acidic component,). It may be an acid component).
また、pH調整剤は、単独で又は2種以上の成分(pH調整剤)の組み合わせにより、緩衝作用を有していてもよい。2種以上の成分を組み合わせる場合、当該組み合わせ(pH調整剤全体)において塩基性又は酸性であってもよい(塩基性又は酸性を示してもよい)。 Further, the pH adjusting agent may have a buffering action alone or by a combination of two or more kinds of components (pH adjusting agents). When two or more components are combined, the combination (whole pH adjuster) may be basic or acidic (may be basic or acidic).
pH調整剤としては、例えば、無機酸[例えば、リン酸、ピロリン酸、メタリン酸、ポリリン酸、硫酸、硝酸、塩酸(塩化水素)等]、無機酸(例えば、弱酸)の塩[例えば、リン酸水素塩(例えば、リン酸水素ナトリウム)、リン酸二水素塩(例えば、リン酸二水素ナトリウム)]、有機酸{例えば、モノカルボン酸(例えば、酢酸、ソルビン酸)、ポリカルボン酸(例えば、シュウ酸、コハク酸、マレイン酸、フマル酸)、オキシカルボン酸[例えば、ヒドロキシモノカルボン酸(例えば、グリコール酸、乳酸、グルコン酸)、ヒドロキシポリカルボン酸(例えば、酒石酸、リンゴ酸、クエン酸等)等]等のカルボン酸}、有機酸(例えば、弱酸)の塩[例えば、カルボン酸塩(例えば、酢酸ナトリウム、酒石酸ナトリウム、コハク酸ナトリウム、クエン酸ナトリウム(クエン酸三ナトリウム等)の前記カルボン酸の塩)]、無機塩基[例えば、金属水酸化物(例えば、水酸化ナトリウム、水酸化カリウム、水酸化カルシウム等)等]、有機塩基{例えば、アミン類[例えば、アルカノールアミン(例えば、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン、N-メチルエタノールアミン、N-アミノエチルエタノールアミン、N-メチルジエタノールアミン等)等]等}、アミノ酸(例えば、グリシン等)等が挙げられる。 Examples of the pH adjuster include inorganic acids [eg, phosphoric acid, pyrophosphate, metaphosphate, polyphosphoric acid, sulfuric acid, nitrate, hydrochloric acid (hydrogen chloride), etc.] and salts of inorganic acids (eg, weak acids) [eg, phosphorus]. Acid hydrogen salt (eg, sodium hydrogen phosphate), dihydrogen phosphate (eg, sodium dihydrogen phosphate)], organic acid {eg, monocarboxylic acid (eg, acetic acid, sorbic acid), polycarboxylic acid (eg, eg acetic acid, sorbic acid). , Shuic acid, succinic acid, maleic acid, fumaric acid), oxycarboxylic acid [eg, hydroxymonocarboxylic acid (eg, glycolic acid, lactic acid, gluconic acid), hydroxypolycarboxylic acid (eg, tartrate acid, malic acid, citric acid) Etc.], etc.}, salts of organic acids (eg, weak acids) [eg, sodium acetate, sodium tartrate, sodium succinate, sodium citrate (trisodium citrate, etc.) (Salts of carboxylic acids)], inorganic bases [eg, metal hydroxides (eg, sodium hydroxide, potassium hydroxide, calcium hydroxide, etc.), etc.], organic bases {eg, amines [eg, alkanolamines (eg, alkanolamines). Monoethanolamine, diethanolamine, triethanolamine, diisopropanolamine, triisopropanolamine, N-methylethanolamine, N-aminoethylethanolamine, N-methyldiethanolamine, etc.)], etc.}, amino acids (eg, glycine, etc.), etc. Can be mentioned.
pH調整剤は、単独で又は2種以上組み合わせて使用してもよい。 The pH regulator may be used alone or in combination of two or more.
特に、pH調整剤としては、塩基性を示すpH調整剤を少なくとも使用してもよい。 In particular, as the pH adjuster, at least a pH adjuster exhibiting basicity may be used.
組成物がpH調整剤を含む場合、組成物において、pH調整剤の割合は、その種類や所望のpH等に応じて選択できる。例えば無水リン酸一水素ナトリウム及び無水リン酸二水素ナトリウムの場合、0.01~1w/v%、好ましくは0.05~0.5w/v%、さらに好ましくは0.1~0.3w/v%等であってもよい。 When the composition contains a pH adjuster, the proportion of the pH adjuster in the composition can be selected according to the type, desired pH and the like. For example, in the case of anhydrous sodium monohydrogen phosphate and anhydrous sodium dihydrogen phosphate, it is 0.01 to 1 w / v%, preferably 0.05 to 0.5 w / v%, and more preferably 0.1 to 0.3 w /. It may be v% or the like.
本発明の一態様の組成物では、pH調整剤等の他の成分が共存しても、パラベンの安定性を効率よく実現しうるため、パラベンの安定性を担保しつつ、所望のpHに調整しやすい。 In the composition of one aspect of the present invention, the stability of paraben can be efficiently realized even if other components such as a pH adjuster coexist, so that the pH can be adjusted to a desired level while ensuring the stability of paraben. It's easy to do.
(他の成分)
組成物は、他の成分を含んでいてもよい。なお、塩基性ないし酸性を示す他の成分は、pH調整剤として機能してもよい。
(Other ingredients)
The composition may contain other components. In addition, other components showing basicity or acidity may function as a pH adjuster.
他の成分としては、組成物の使用目的や態様に応じて選択でき、例えば、湿潤剤(保湿剤)、粘稠剤(粘度調整剤、増粘剤)、起泡剤、殺菌(抗菌)剤、防腐剤、界面活性剤(カチオン性界面活性剤、アニオン性界面活性剤、非イオン性界面活性剤、両性界面活性剤)、消臭剤、香料、薬用成分(生理活性成分、有効成分)、安定(化)剤、改良剤、可塑剤、可溶(化)剤、還元剤、緩衝剤、基剤、揮発補助剤、矯味剤、共力剤、懸濁(化)剤、抗酸化剤、効力増強剤、持続化剤、湿潤調整剤、充填剤、消泡剤、清涼化剤、増強剤、着香剤、着色剤、等張化剤、軟化剤、乳化剤、粘稠化剤、発泡剤、皮膚保護剤、浮遊剤、分散剤、噴射剤、芳香剤、防錆剤、保存剤、溶解剤、溶解補助剤等が挙げられる。 Other components can be selected according to the purpose and mode of use of the composition, for example, a wetting agent (moisturizing agent), a thickening agent (viscosity adjusting agent, thickening agent), a defoaming agent, and a bactericidal (antibacterial) agent. , Preservatives, surfactants (cationic surfactants, anionic surfactants, nonionic surfactants, amphoteric surfactants), deodorants, fragrances, medicinal ingredients (physiologically active ingredients, active ingredients), Stabilizers, improvers, plasticizers, solubilizers, reducing agents, buffers, bases, volatile aids, flavoring agents, surfactants, suspending agents, antioxidants, Efficacy enhancer, sustainer, wetting adjuster, filler, defoamer, refreshing agent, enhancer, flavoring agent, colorant, tonicity agent, softening agent, emulsifier, thickening agent, foaming agent , Skin protectants, buoyants, dispersants, propellants, fragrances, rust preventives, preservatives, solubilizers, solubilizers and the like.
なお、他の成分は、複数の機能を兼ね備えていてもよい。例えば、その種類によっては、界面活性剤は殺菌(消毒)剤や起泡剤(発泡剤)等として、湿潤剤は粘稠剤等として、機能しうる。 In addition, other components may have a plurality of functions. For example, depending on the type, the surfactant may function as a bactericidal (disinfectant) agent, a foaming agent (foaming agent), or the like, and the wetting agent may function as a viscous agent or the like.
このような他の成分の一例を挙げると、例えば、多価アルコール{例えば、アルカンジオール(例えば、エチレングリコール、プロピレングリコール、1,3-ブチレングリコール、1,4-ブタンジオール、3-メチル-1,3-ブタンジオール、ペンタンジオール)、アルカンジオールの多量体(例えば、ジエチレングリコール、トリエチレングリコール、ジプロピレングリコール)、ポリエチレングリコール(マクロゴール)、ポリオキシエチレンポリオキシプロピレングリコール(ポロキサマー)、3以上のヒドロキシ基を有する多価アルコール[例えば、グリセリン、ジグリセリン、糖又は糖アルコール(例えば、トレハロース等)等]等}、多糖類又はその誘導体(例えば、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、疎水化ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース(カルボキシメチルセルロースナトリウム)、ヒアルロン酸(ヒアルロン酸ナトリウム)、グアーガム、カラギーナン、ローカストビーンガム、キサンタンガム等)、カチオン性界面活性剤(例えば、セチルピリジニウム塩化物、塩化ベンゼトニウム塩化物、デカリニウム塩化物、ジデシルジメチルアンモニウム塩化物、N-ヤシ油脂肪酸アシル-L-アルギニンエチル・DL-ピロリドンカルボン酸塩等)、両性界面活性剤(例えば、ラウリルジメチルアミンオキシド、アルキルジアミノエチルグリシン塩酸塩等)、非イオン性界面活性剤[例えば、ポリオキシエチレン硬化ヒマシ油、アルキルグルコシド(例えば、デシルグルコシド、カプリリル/カプリルグルコシド等)等]、抗菌剤又は防腐剤[例えば、フェノキシエタノール、グルコン酸クロルヘキシジン、安息香酸又はその塩(安息香酸ナトリウム等)、デヒドロ酢酸又はその塩(デヒドロ酢酸ナトリウム等)、グリチルリチン酸又はその塩(グリチルリチン酸ジカリウム等)等]、溶解補助剤(例えば、ミリスチン酸イソプロピル等)、可溶(化)剤(例えば、グリセリン脂肪酸エステル等)、安定(化)剤(例えば、トコフェロール酢酸エステル等)、湿潤剤ないし軟化剤(例えば、アラントイン、尿素、2-メタクリロイルオキシエチルホスホリルコリン・メタクリル酸ブチル共重合体液(リピジュア(登録商標))等)等が挙げられる。 Examples of such other components include polyhydric alcohols {eg, alcan diols (eg, ethylene glycol, propylene glycol, 1,3-butylene glycol, 1,4-butanediol, 3-methyl-1). , 3-Butanediol, Pentandiol), multimers of alcohol (eg, diethylene glycol, triethylene glycol, dipropylene glycol), polyethylene glycol (macrogol), polyoxyethylene polyoxypropylene glycol (poroxamer), 3 or more Polyhydric alcohols with hydroxy groups [eg, glycerin, diglycerin, sugars or sugar alcohols (eg, trehalose, etc.)], etc.}, polysaccharides or derivatives thereof (eg, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydrophobic). Hydroxypropylmethylcellulose, carboxymethylcellulose (sodium carboxymethylcellulose), hyaluronic acid (sodium hyaluronate), guar gum, carrageenan, locust bean gum, xanthan gum, etc.), cationic surfactants (eg, cetylpyridinium chloride, benzethonium chloride chloride) , Decalinium chloride, didecyldimethylammonium chloride, N-coconut oil fatty acid acyl-L-arginine ethyl DL-pyrrolidone carboxylate, etc.), amphoteric surfactants (eg, lauryldimethylamine oxide, alkyldiaminoethylglycine hydrochloride) Salts, etc.), nonionic surfactants [eg, polyoxyethylene hydrogenated castor oil, alkyl glucosides (eg, decyl glucoside, caprylyl / capryl glucoside, etc.), etc.], antibacterial agents or preservatives [eg, phenoxyethanol, chlorhexidine gluconate, etc.] , Dehydroacetic acid or a salt thereof (sodium benzoate, etc.), Dehydroacetic acid or a salt thereof (sodium dehydroacetate, etc.), Glycyrrhizinic acid or a salt thereof (dipotassium glycyrrhizinate, etc.), etc.], Dissolution aid (eg, isopropyl myristate, etc.) , Solubilizing agents (eg, glycerin fatty acid esters, etc.), Stabilizing agents (eg, tocopherol acetate, etc.), Wetting or softening agents (eg, allantin, urea, 2-methacryloyloxyethyl phosphorylcholine methacryl) Examples thereof include butyl acid acid copolymer liquid (lipidure (registered trademark)) and the like.
他の成分は、単独で又は2種以上組み合わせて使用してもよい。 Other ingredients may be used alone or in combination of two or more.
本発明の一態様の組成物では、上記のような他の成分(例えば、多価アルコール、多糖類又はその誘導体、アラントイン、界面活性剤等)が共存しても、パラベンの安定性を効率よく実現しうるため、パラベンの安定性を担保しつつ、他の成分の種類に応じた機能を組成物に効率よく付与しうる。 In the composition of one aspect of the present invention, the stability of paraben is efficiently maintained even in the presence of other components as described above (for example, polyhydric alcohol, polysaccharide or derivative thereof, allantin, surfactant, etc.). Since it can be realized, it is possible to efficiently impart functions according to the types of other components to the composition while ensuring the stability of the paraben.
一方、本発明の組成物は、上記のような他の成分を含んでいなくてもよい。例えば、本発明では、塩化ベンザルコニウム及び/又はパラベンの機能を効率よく発揮(発現)しうるため、組成物は抗菌剤又は防腐剤(例えば、フェノキシエタノール)を含んでいてもよいが、含んでいなくてもよい。 On the other hand, the composition of the present invention does not have to contain other components as described above. For example, in the present invention, the composition may contain an antibacterial agent or an antiseptic (for example, phenoxyethanol) because the functions of benzalkonium chloride and / or paraben can be efficiently exerted (expressed). You don't have to.
組成物が他の成分を含有する場合、組成物において、他の成分の割合は、その種類や使用目的等に応じて、適宜選択できる。 When the composition contains other components, the ratio of the other components in the composition can be appropriately selected according to the type, purpose of use and the like.
組成物における他の成分(の総量)は、例えば、60w/v%以下、好ましくは50w/v%以下、さらに好ましくは30w/v%以下(例えば、20w/v%以下、15w/v%以下、10w/v%以下等)等であってもよく、0.001w/v%以上、好ましくは0.01w/v%以上、さらに好ましくは0.1w/v%以上(例えば、0.15w/v%以上、0.2w/v%以上等)等であってもよい。 The other components (total amount) in the composition are, for example, 60 w / v% or less, preferably 50 w / v% or less, more preferably 30 w / v% or less (for example, 20 w / v% or less, 15 w / v% or less). (10 w / v% or less, etc.), etc., 0.001 w / v% or more, preferably 0.01 w / v% or more, still more preferably 0.1 w / v% or more (for example, 0.15 w / v). It may be v% or more, 0.2 w / v% or more, etc.).
組成物が多価アルコールを含有する場合、組成物における多価アルコールの割合は、50w/v%以下(例えば、45w/v%以下)、好ましくは30w/v%以下(例えば、20w/v%以下)、さらに好ましくは10w/v%以下(例えば、5w/v%以下、3w/v%以下、1w/v%以下)等であってもよく、0.001w/v%以上、好ましくは0.01w/v%以上、さらに好ましくは0.05w/v%以上(例えば、0.1w/v%以上)等であってもよい。 When the composition contains a polyhydric alcohol, the proportion of the polyhydric alcohol in the composition is 50 w / v% or less (eg, 45 w / v% or less), preferably 30 w / v% or less (eg, 20 w / v%). Below), more preferably 10 w / v% or less (for example, 5 w / v% or less, 3 w / v% or less, 1 w / v% or less), and more, 0.001 w / v% or more, preferably 0. It may be 0.01 w / v% or more, more preferably 0.05 w / v% or more (for example, 0.1 w / v% or more).
組成物が多糖類又はその誘導体を含有する場合、組成物における多糖類又はその誘導体の割合は、5w/v%以下、好ましくは3w/v%以下、さらに好ましくは1.5w/v%以下等であってもよく、0.001w/v%以上、好ましくは0.005w/v%以上、さらに好ましくは0.01w/v%以上等であってもよい。 When the composition contains a polysaccharide or a derivative thereof, the ratio of the polysaccharide or its derivative in the composition is 5 w / v% or less, preferably 3 w / v% or less, more preferably 1.5 w / v% or less, and the like. It may be 0.001 w / v% or more, preferably 0.005 w / v% or more, more preferably 0.01 w / v% or more, and the like.
組成物がアラントインを含有する場合、組成物におけるアラントインの割合は、3w/v%以下、好ましくは1w/v%以下、さらに好ましくは0.1w/v%以下(例えば、0.05w/v%以下)等であってもよく、0.001w/v%以上、好ましくは0.005w/v%以上、さらに好ましくは0.01w/v%以上等であってもよい。 When the composition contains allantoin, the proportion of allantoin in the composition is 3 w / v% or less, preferably 1 w / v% or less, more preferably 0.1 w / v% or less (eg, 0.05 w / v%). The following) may be used, and may be 0.001 w / v% or more, preferably 0.005 w / v% or more, and more preferably 0.01 w / v% or more.
他の成分とパラベンの割合は、例えば、パラベン1質量部に対して、他の成分0.1質量部以上、好ましくは0.5質量部以上、さらに好ましくは1質量部以上であってもよく、50質量部以下、好ましくは30質量部以下(例えば、20質量部以下)、さらに好ましくは10質量部以下であってもよい。 The ratio of the other component to the paraben may be, for example, 0.1 part by mass or more, preferably 0.5 part by mass or more, and more preferably 1 part by mass or more of the other component with respect to 1 part by mass of the paraben. , 50 parts by mass or less, preferably 30 parts by mass or less (for example, 20 parts by mass or less), and more preferably 10 parts by mass or less.
(溶媒)
組成物は、溶媒(担体、溶媒成分)を含んでいてもよい。
(solvent)
The composition may contain a solvent (carrier, solvent component).
溶媒としては、例えば、水、非水溶媒[例えば、アルコール(又はモノオール、例えば、エタノール、イソプロパノール等の低級アルコール)]等が挙げられる。 Examples of the solvent include water, non-aqueous solvents [for example, alcohols (or monools, for example, lower alcohols such as ethanol and isopropanol)] and the like.
なお、上記のpH調整剤(例えば、アルカノールアミン等)や他の成分(例えば、多価アルコール等)を、非水溶媒として使用することもできる。 In addition, the above-mentioned pH adjuster (for example, alkanolamine etc.) and other components (for example, polyhydric alcohol etc.) can also be used as a non-aqueous solvent.
非水溶媒は、代表的には、水溶性溶媒(又は水と混和する溶媒)であってもよい。 The non-aqueous solvent may be typically a water-soluble solvent (or a solvent miscible with water).
溶媒は、通常、少なくとも水で構成するのが好ましい。すなわち、本発明の組成物は、通常、少なくとも水を含有してもよく、水と非水溶媒を含んでいてもよい。 The solvent is usually preferably composed of at least water. That is, the composition of the present invention may usually contain at least water, or may contain water and a non-aqueous solvent.
なお、水と非水溶媒とを併用する場合、水の割合は、水及び非水溶媒の総量に対して、50質量%以上、好ましくは70質量%以上、さらに好ましくは90質量%以上であってもよい。 When water and a non-aqueous solvent are used in combination, the ratio of water is 50% by mass or more, preferably 70% by mass or more, and more preferably 90% by mass or more with respect to the total amount of water and the non-aqueous solvent. You may.
特に、本発明の組成物は、低級アルコール(特に、エタノール)を含んでいても少量であるか又は実質的に含んでいなくてもよい。本発明の組成物では、エタノール等の抗菌性能を発揮しうる溶媒を含有しなくても、塩化ベンザルコニウムにより抗菌性能を効率よく発揮しうる。そのため、本発明では、このようなアルコール(特に、エタノール)含量が少ないか又は実質的に含有しない[又はアルコール(特に、エタノール)フリーの]組成物をも提供できる。 In particular, the composition of the present invention may contain, in small amounts, or substantially no lower alcohol (particularly ethanol). In the composition of the present invention, benzalkonium chloride can efficiently exhibit antibacterial performance even if it does not contain a solvent such as ethanol that can exhibit antibacterial performance. Therefore, the present invention can also provide such [or alcohol (particularly, ethanol) -free] compositions with low or substantially no alcohol (particularly ethanol) content.
このような組成物において、エタノール(低級アルコール)の割合は、例えば、5質量%以下、好ましくは3質量%以下、さらに好ましくは1質量%以下であってもよく、特に、0質量%であってもよい(すなわち、組成物は、エタノールを含有しなくてもよい)。 In such a composition, the proportion of ethanol (lower alcohol) may be, for example, 5% by mass or less, preferably 3% by mass or less, more preferably 1% by mass or less, and particularly 0% by mass. It may (ie, the composition may not contain ethanol).
(pH)
本発明の組成物のpHは、例えば、3以上(例えば、4以上)程度の範囲から選択でき、4.2以上(例えば、4.5以上、4.8以上)、好ましくは5以上(例えば、5.2以上、5.5以上、5.8以上、5.9以上)、さらに好ましくは6以上であってもよい。
(PH)
The pH of the composition of the present invention can be selected from a range of, for example, about 3 or more (for example, 4 or more), 4.2 or more (for example, 4.5 or more, 4.8 or more), and preferably 5 or more (for example, 4 or more). 5.2 or more, 5.5 or more, 5.8 or more, 5.9 or more), more preferably 6 or more.
組成物のpHの上限値は、例えば、10以下程度の範囲から選択でき、9以下、8.5以下、8以下、7.5以下、7以下、6.5以下等であってもよい。 The upper limit of the pH of the composition can be selected from a range of, for example, about 10 or less, and may be 9 or less, 8.5 or less, 8 or less, 7.5 or less, 7 or less, 6.5 or less, and the like.
特に、組成物のpHは、殺菌性能等の観点から、5.1以上(例えば、5.2以上、5.3以上、5.4以上、5.5以上、5.6以上、5.7以上、5.8以上、5.9以上、6以上)程度であるのが好ましい。 In particular, the pH of the composition is 5.1 or higher (for example, 5.2 or higher, 5.3 or higher, 5.4 or higher, 5.5 or higher, 5.6 or higher, 5.7 or higher) from the viewpoint of bactericidal performance or the like. It is preferably about 5.8 or more, 5.9 or more, 6 or more).
一方、組成物のpHは、パラベンの安定性等の観点から、7.4以下(例えば、7.3以下、7.2以下、7.1以下)程度であってもよく、好ましくは7以下(例えば、6.9以下、6.8以下、6.7以下、6.6以下)、さらに好ましくは6.5以下であってもよい。 On the other hand, the pH of the composition may be about 7.4 or less (for example, 7.3 or less, 7.2 or less, 7.1 or less) from the viewpoint of paraben stability and the like, and is preferably 7 or less. (For example, 6.9 or less, 6.8 or less, 6.7 or less, 6.6 or less), more preferably 6.5 or less.
そのため、組成物のpHは、殺菌性能等とパラベンの安定性等とを両立させるという観点から、これらの範囲を兼ね備える(重複する)範囲(例えば、5.5~7、6~6.5等)であってもよい。 Therefore, the pH of the composition is in a range (for example, 5.5 to 7, 6 to 6.5, etc.) that combines (overlaps) these ranges from the viewpoint of achieving both bactericidal performance and the stability of parabens. ) May be.
pHは、例えば、第十七改正日本薬局方 一般試験法 2.54「pH測定法」に従って測定してもよい。なお、pHは、例えば、なりゆき温度(例えば、20~25℃)における値であってもよい。 The pH may be measured, for example, in accordance with the 17th revised Japanese Pharmacopoeia General Test Method 2.54 “pH Measurement Method”. The pH may be, for example, a value at a growing temperature (for example, 20 to 25 ° C.).
(形態・製造方法)
組成物の形態(性状)は、通常、液状である。液状の組成物は、組成物の成分等により、溶液、懸濁液、乳化物等であってもよく、クリーム(クリーム状)であってもよい。また、組成物(使用時の組成物)は、ゲル(ゲル状)、フォーム(泡)状等であってもよい。
(Form / Manufacturing method)
The form (property) of the composition is usually liquid. The liquid composition may be a solution, a suspension, an emulsion, or the like, or may be a cream (cream), depending on the components of the composition and the like. Further, the composition (composition at the time of use) may be in the form of a gel (gel), foam (foam) or the like.
液状の組成物の粘度は、例えば、30000mPa・s以下、好ましくは10000mPa・s以下、さらに好ましくは5000mPa・s以下であってもよく、1mPa・s以上(例えば、2mPa・s以上、3mPa・s以上、5mPa・s以上、10mPa・s以上等)であってもよい。
なお、粘度は、例えば、第十七改正日本薬局方 一般試験法 2.53「粘度測定法」第1法毛細管粘度計法に従い、ウベローデ型粘度計(温度20℃)にて測定できる。
The viscosity of the liquid composition may be, for example, 30,000 mPa · s or less, preferably 10,000 mPa · s or less, more preferably 5000 mPa · s or less, and 1 mPa · s or more (for example, 2 mPa · s or more, 3 mPa · s). 5 mPa · s or more, 10 mPa · s or more, etc.).
The viscosity can be measured with a Uberode type viscometer (temperature 20 ° C.) according to, for example, the 17th revised Japanese Pharmacopoeia general test method 2.53 “viscosity measurement method” 1st method capillary viscometer method.
組成物は、各成分を混合することより得ることができる。混合方法(製造方法)は、特に限定されず、慣用の方法を利用できる。 The composition can be obtained by mixing each component. The mixing method (manufacturing method) is not particularly limited, and a conventional method can be used.
(用途)
組成物の用途は、特に限定されず、種々の用途に使用できる。例えば、組成物は、塩化ベンザルコニウムの消毒(殺菌)性能を生かした用途に適用できる。
(Use)
The use of the composition is not particularly limited, and it can be used for various uses. For example, the composition can be applied to applications that take advantage of the disinfection (sterilization) performance of benzalkonium chloride.
一方、組成物は、パラベンを含有するため、パラベンの機能(防腐性能等)を生かした用途にも適用できる。 On the other hand, since the composition contains paraben, it can be applied to applications that make the best use of the function of paraben (antiseptic performance, etc.).
本発明の組成物は、代表的には、消毒用(消毒剤)として、特に、外用消毒用(外用消毒剤)として好適に使用できる。外用(消毒剤)としては、皮膚(消毒剤)[例えば、手指(消毒剤)]が挙げられる。本発明の組成物は、安全な成分で構成することが可能であり、外用(皮膚)にも好適である。 The composition of the present invention is typically suitably used for disinfection (disinfectant), and in particular, for external disinfection (external disinfectant). Examples of external use (disinfectant) include skin (disinfectant) [for example, fingers (disinfectant)]. The composition of the present invention can be composed of safe ingredients and is also suitable for external use (skin).
特に、本発明では、エタノール(アルコール)を実質的に含有しない組成物を得ることもできるので、このような組成物は、エタノール(アルコール)に過敏な対象者(利用者)においても適用できる。 In particular, in the present invention, it is possible to obtain a composition that does not substantially contain ethanol (alcohol), so that such a composition can be applied to a subject (user) who is sensitive to ethanol (alcohol).
(使用形態)
組成物の使用形態(適用方法)は、組成物の使用目的や形態(性状)等によって適宜選択でき、例えば、対象(適用)部位に適用することで使用できる。
(Usage pattern)
The form of use (application method) of the composition can be appropriately selected depending on the purpose of use, form (property), etc. of the composition, and can be used, for example, by applying it to a target (application) site.
具体的な適用方法としては、対象部位への塗布(付着)が挙げられる。具体的な適用方法としては、例えば、液状の組成物の場合の容器からの滴下又はポンプによる噴霧、ゲル状の組成物の場合の容器からの滴下又はポンプからの吐出、泡状(フォーム)の組成物の場合のポンプによる吐出又はガス(圧縮ガス)を伴う噴霧等が挙げられる。
また、組成物(薬液)を、ガーゼ、タオル、モップ、ワイプ等に取り、物品や環境表面に塗布または清拭してもよい。さらに、組成物(薬液)中に対象物を浸漬する方法であってもよい。
Specific application methods include application (adhesion) to the target site. Specific application methods include, for example, dropping from a container or spraying with a pump in the case of a liquid composition, dropping from a container or discharging from a pump in the case of a gel-like composition, and foam. Examples of the composition include discharge by a pump or spraying with gas (compressed gas).
Further, the composition (chemical solution) may be taken on gauze, a towel, a mop, a wipe or the like and applied or wiped on an article or an environmental surface. Further, a method of immersing the object in the composition (chemical solution) may be used.
なお、組成物は、適当な容器に収容されていてもよい。適用方法に合わせて、容器を選択してもよい。 The composition may be contained in a suitable container. The container may be selected according to the application method.
例えば、組成物を、スプレー容器(スプレーボトル)に収容することで、噴霧(噴射)可能としてもよく、泡を形成可能な容器(泡ボトル、例えば、メッシュ付きの容器)に収容することで、泡状として適用(塗布、噴霧)可能としてもよい。 For example, the composition may be sprayed (sprayed) by accommodating it in a spray container (spray bottle), or by accommodating it in a container capable of forming bubbles (foam bottle, for example, a container with a mesh). It may be possible to apply (apply, spray) as a foam.
組成物の適用量(使用量)は、使用目的等に応じて選択できるが、例えば、手指消毒では1回あたり、0.1~6mL、好ましくは0.2~3mL、さらに好ましくは0.4~1mL等であってもよい。 The applied amount (used amount) of the composition can be selected according to the purpose of use and the like. For example, in the case of hand disinfection, 0.1 to 6 mL, preferably 0.2 to 3 mL, and more preferably 0.4 is applied once. It may be ~ 1 mL or the like.
また、組成物の適用量(使用量)は、使用目的等に応じて選択できるが、例えば、手指消毒では1回あたり、塩化ベンザルコニウムとして、0.05~12mg、好ましくは0.1~6mg、さらに好ましくは0.2~2mg等であってもよい。 The application amount (usage amount) of the composition can be selected according to the purpose of use and the like. For example, in the case of hand disinfection, 0.05 to 12 mg, preferably 0.1 to 12 mg of benzalkonium chloride is used at one time. It may be 6 mg, more preferably 0.2 to 2 mg or the like.
[各種方法]
本発明では、上記のように、組成物の殺菌性能(殺菌力)を向上(改善)したり、パラベンの安定性を向上(改善)しうる。
そのため、本発明には、次の方法も含まれる。
[Various methods]
In the present invention, as described above, the bactericidal performance (bactericidal activity) of the composition can be improved (improved) and the stability of paraben can be improved (improved).
Therefore, the present invention also includes the following method.
(1)塩化ベンザルコニウムを含有する組成物に、パラベンを配合し(含有させ)、組成物の殺菌力を向上する方法。 (1) A method of blending (containing) paraben with a composition containing benzalkonium chloride to improve the bactericidal activity of the composition.
(2)パラベンを含有する組成物に、塩化ベンザルコニウムを配合し(含有させ)、組成物におけるパラベンの安定性を向上する方法。 (2) A method of blending (containing) benzalkonium chloride with a composition containing paraben to improve the stability of paraben in the composition.
なお、これらの方法において、塩化ベンザルコニウム及びパラベンの配合以外については、前記例示のものであってもよい。例えば、塩化ベンザルコニウムやパラベンの配合量(割合)は、前記の範囲から選択してもよく、pHや他の成分(例えば、pH調整剤)の配合の有無やその割合等も前記例示のものとしてもよい。 In these methods, the above-mentioned examples may be used except for the blending of benzalkonium chloride and paraben. For example, the blending amount (ratio) of benzalkonium chloride or paraben may be selected from the above range, and the presence or absence of blending of pH and other components (for example, a pH adjuster) and the percentage thereof are also exemplified above. It may be a thing.
以下に、実施例により本発明を更に詳細に説明するが、本発明はこれに限定されるものではない。 Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited thereto.
なお、実施例において、各種測定や試験は、次のようにして行った。 In the examples, various measurements and tests were performed as follows.
pH測定
第十七改正日本薬局方 一般試験法 2.54「pH測定法」に従って、なりゆき温度(20~25℃)にて測定した。
pH measurement The measurement was carried out at the Nariyuki temperature (20 to 25 ° C) according to the 17th revised Japanese Pharmacopoeia General Test Method 2.54 “pH Measurement Method”.
各成分の含量の測定
第十七改正日本薬局方 一般試験法 2.01「液体クロマトグラフィー(内標準法)」に従って測定した。
Measurement of the content of each component The measurement was performed according to the 17th revised Japanese Pharmacopoeia General Test Method 2.01 "Liquid Chromatography (Internal Standard Method)".
Time Kill試験(ASTM E2315-16)1
各組成物につき、Time-kill試験(ASTM E2315-16)を行い、対数減少値5.0(減菌率99.999%)に到達する時間を求めた。なお、菌には、下記の2種を用いた。
バークホルデリア・セパシア(B.cepacia) NBRC 15124株
カンジダ・アルビカンス(C.albicans) NBRC 1594株
Time Kill Test (ASTM E2315-16) 1
A Time-kill test (ASTM E2315-16) was performed on each composition to determine the time to reach a logarithmic reduction value of 5.0 (sterilization rate 99.999%). The following two species were used as the fungus.
Burkholderia Sepasia NBRC 15124 strain Candida albicans NBRC 1594 strain
Time Kill試験(ASTM E2315-16)2
各組成物につき、Time-kill試験(ASTM E2315-16)を行い、30秒、60秒における対数減少値を求めた。なお、菌には、下記を用いた。
バークホルデリア・セパシア(B.cepacia) NBRC 15124株
Time Kill Test (ASTM E2315-16) 2
A Time-kill test (ASTM E2315-16) was performed on each composition, and the logarithmic reduction values at 30 seconds and 60 seconds were determined. The following was used as the fungus.
Burkholderia Sepasia NBRC 15124 strain
安定性試験
各組成物60mLをポリエチレン製容器へ充填し、ポリプロピレン製キャップで施栓した供試検体を、50℃で保存し、時点[試験開始時、10日、20日、40日(試験例Bのみ)]毎に、各成分の含量(4-ヒドロキシ安息香酸、パラベン)を測定した。また、10日、20日、40日(試験例Bのみ)毎に、pHを測定した。
Stability test 60 mL of each composition was filled in a polyethylene container, and the test sample capped with a polypropylene cap was stored at 50 ° C. at time points [at the start of the test, 10 days, 20 days, 40 days (Test Example B). Only)], the content of each component (4-hydroxybenzoic acid, paraben) was measured. In addition, the pH was measured every 10 days, 20 days, and 40 days (only in Test Example B).
なお、pHは前記の方法にて、また、各成分の含量は前記の方法にて測定し、パラベン(メチルパラベン、エチルパラベン)については試験開始時の含量を100%として、10日、20日、40日後における含量(相対値(%))を算出した。 The pH was measured by the above method, and the content of each component was measured by the above method. For parabens (methylparaben, ethylparaben), the content at the start of the test was set to 100%, and 10 days and 20 days. The content (relative value (%)) after 40 days was calculated.
試験例A
下記表1に示すように、各成分を所定の分量比で混合し、各組成物(供試製剤)を得た。
Test Example A
As shown in Table 1 below, each component was mixed in a predetermined amount ratio to obtain each composition (test preparation).
そして、得られた各組成物について、Time Kill試験1及び安定性試験を行った。結果を下記表1にまとめて示す。 Then, Time Kill test 1 and stability test were performed on each of the obtained compositions. The results are summarized in Table 1 below.
なお、表1において、「部」とは質量部を、「N.D」とは検出限界(検出されなかったこと)を示す(以下同じ)。 In Table 1, "part" indicates a mass part, and "ND" indicates a detection limit (not detected) (the same applies hereinafter).
上記表の結果は、塩化ベンザルコニウムを含む組成物では、エタノールフリーであっても、特定条件(パラベンを含有する条件、好ましくはさらにpHを概ね5.5以上、特に、6以上とする条件)において、殺菌性能を効率よく発揮できることを示した(製剤A1~A5、特に製剤A1~A4等)。 The results in the above table show that in the composition containing benzalkonium chloride, even if it is ethanol-free, specific conditions (conditions containing parabens, preferably further pH of about 5.5 or more, particularly 6 or more) are obtained. ), It was shown that the bactericidal performance can be efficiently exhibited (formulations A1 to A5, particularly formulations A1 to A4, etc.).
特に、皮膚(手指等)消毒用などとしての使用を考慮した場合、使用時間(乾燥時間)は短い(例えば、60秒以内等である)のが好ましく、このような短時間(例えば、菌によっては、15秒以内や60秒以内等)のうちに、殺菌できることは極めて有用である。 In particular, when considering the use for disinfecting the skin (hands and fingers, etc.), it is preferable that the use time (drying time) is short (for example, within 60 seconds), and such a short time (for example, due to bacteria). It is extremely useful to be able to sterilize within 15 seconds, 60 seconds, etc.).
一方、安定性試験の結果から、経時的に、pHはほぼ変動しなかったものの、パラベンの分解(加水分解)により生じるものと考えられる4-ヒドロキシ安息香酸の量は増え、パラベンの残存量は減る(パラベンの消失が増える)傾向にあったが、この傾向は、塩化ベンザルコニウムを含有し、概ねpH7以下[特に、6.5以下(5~6.5、5.5~6.5等)]の条件において顕著に抑えられることがわかった(製剤A2~A6、特に製剤A3~A6)。 On the other hand, from the results of the stability test, although the pH did not fluctuate over time, the amount of 4-hydroxybenzoic acid, which is considered to be caused by the decomposition (hydrolysis) of paraben, increased, and the residual amount of paraben increased. There was a tendency to decrease (increase the disappearance of parabens), but this tendency was that it contained benzalconium chloride and was generally pH 7 or less [especially 6.5 or less (5 to 6.5, 5.5 to 6.5). Etc.)] was found to be significantly suppressed (formulations A2 to A6, particularly formulations A3 to A6).
そのため、殺菌性能(の維持)とパラベンの機能(例えば、防腐性能)の維持を高いレベルで両立させるという観点からは、塩化ベンザルコニウムとパラベンを含有し、pH5.5~7(特に、6~6.5)の組成物(製剤A2~A5、特に製剤A3~A4)が極めて好適であることもわかった。 Therefore, from the viewpoint of achieving both bactericidal performance (maintenance) and paraben function (for example, antiseptic performance) at a high level, it contains benzalkonium chloride and paraben, and has a pH of 5.5 to 7 (particularly 6). It was also found that the compositions of ~ 6.5) (formulations A2 to A5, particularly formulations A3 to A4) are extremely suitable.
また、上記表の結果は、パラベンの中でもエチルパラベンの安定化効果が総じて高いこと、また、メチルパラベンについては特定のpH条件下(例えば、7以下、特に6.5以下)において著しく安定性を改善できることを示すものである。 In addition, the results in the above table show that the stabilizing effect of ethylparaben is generally high among parabens, and that the stability of methylparaben is significantly improved under specific pH conditions (for example, 7 or less, particularly 6.5 or less). It shows what you can do.
試験例B
下記表2に示すように、各成分を所定の分量比で混合し、各組成物(供試製剤)を得た。
Test Example B
As shown in Table 2 below, each component was mixed in a predetermined amount ratio to obtain each composition (test preparation).
そして、得られた各組成物について、安定性試験を行った。結果を下記表2にまとめて示す。 Then, a stability test was conducted on each of the obtained compositions. The results are summarized in Table 2 below.
上記表の結果は、パラベンを含む組成物(エタノールフリーの水性組成物)では、他の成分(pH調整剤等)の共存により、パラベンの安定性が低下する傾向にあること、また、塩化ベンザルコニウムによりパラベンの安定性を向上又は改善しうることを示した。 The results in the above table show that in a composition containing paraben (ethanol-free aqueous composition), the stability of paraben tends to decrease due to the coexistence of other components (pH adjuster, etc.), and benzalkonium chloride. It has been shown that luconium can improve or improve the stability of parabens.
試験例C
下記表3に示すように、各成分を所定の分量比で混合し、各組成物(供試製剤)を得た。
Test Example C
As shown in Table 3 below, each component was mixed in a predetermined amount ratio to obtain each composition (test preparation).
そして、得られた各組成物について、Time Kill試験2を行った。結果を下記表3にまとめて示す。 Then, Time Kill test 2 was performed on each of the obtained compositions. The results are summarized in Table 3 below.
上記表の結果は、塩化ベンザルコニウムとパラベンを組み合わせる(さらには、所定のpH領域で組み合わせる)ことにより、殺菌性能をより効率良く発揮できることを示した。 The results in the above table show that the bactericidal performance can be exhibited more efficiently by combining benzalkonium chloride and paraben (further, combining them in a predetermined pH range).
試験例D
下記表4に示すように、各成分を所定の分量比で混合し、各組成物を得た。
Test Example D
As shown in Table 4 below, each component was mixed in a predetermined amount ratio to obtain each composition.
そして、得られた各組成物について、Time Kill試験1及び安定性試験を行ったところ、前記と同様の傾向を示した。 Then, when the Time Kill test 1 and the stability test were performed on each of the obtained compositions, the same tendency as described above was shown.
本発明によれば、消毒用等として使用可能な組成物等を提供できる。 According to the present invention, it is possible to provide a composition or the like that can be used for disinfection or the like.
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020162642A JP2022055190A (en) | 2020-09-28 | 2020-09-28 | Composition containing benzalkonium chloride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020162642A JP2022055190A (en) | 2020-09-28 | 2020-09-28 | Composition containing benzalkonium chloride |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2022055190A true JP2022055190A (en) | 2022-04-07 |
Family
ID=80997995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020162642A Pending JP2022055190A (en) | 2020-09-28 | 2020-09-28 | Composition containing benzalkonium chloride |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2022055190A (en) |
-
2020
- 2020-09-28 JP JP2020162642A patent/JP2022055190A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210337835A1 (en) | Composition containing glycolipids and preservatives | |
AU2016329881B2 (en) | Personal cleansing compositions and methods of stabilizing the microbiome | |
KR100437566B1 (en) | Disinfectant composition comprising alcohol, chlorhexidine and an organic acid | |
KR101734610B1 (en) | Antibacterial cleaning composition | |
US20130244976A1 (en) | Foam-type external skin preparation | |
CA2737263C (en) | Mucomimetic compositions and uses therefore | |
KR20170036058A (en) | Cineole-containing composition for nasal application | |
GB2595047A (en) | Skin disinfectant | |
JP2022055190A (en) | Composition containing benzalkonium chloride | |
JP3636611B2 (en) | Disinfectant composition | |
WO2004105745A1 (en) | Aqueous olanexidine solution, method of preparing the same, and disinfectant | |
JP4695378B2 (en) | Cleaning agent for intraoral device and surface treatment agent for intraoral device | |
JP4526300B2 (en) | Oranexidine aqueous solution, its preparation method and disinfectant | |
JP4541661B2 (en) | Disinfecting and / or disinfecting composition | |
CN112515989B (en) | Compound low-alcohol disinfectant and preparation method thereof | |
JP7059890B2 (en) | disinfectant | |
JP4580153B2 (en) | Disinfecting and / or disinfecting composition | |
JP2004035411A5 (en) | ||
JP7045750B1 (en) | Alcohol-based rubbing-type hand disinfection composition with improved usability | |
CN112351777A (en) | External composition | |
JP6866058B2 (en) | Viscous disinfectant | |
JP2023095650A (en) | Composition comprising surfactant | |
JPH11279205A (en) | Suppression of decomposition of hyaluronic acid preparations | |
JP2012219094A (en) | High-concentration alcohol foaming agent | |
JP2022185525A (en) | disinfectant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201203 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230322 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240112 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240130 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240328 |